CARLSBAD, Calif., July 6, 2017 /PRNewswire/ -- Qualigen, Inc., a privately owned company that provides rapid, easy to use,fully quantitative diagnostic testing solutions, announced today that its Board of Directors has elected Richard David, MD to the Board, effective June 26, 2017.
Dr. David serves as
His clinical and research interests include minimally invasive endoscopic treatment for urologic diseases. He has published extensively and presented at many international conferences in this field.
Dr. David serves as Chief of Surgery at Motion Picture and Television Hospital (MPTVH) in Woodland Hills, CA. In addition to MPTVH, Dr. David serves on staff at Providence St. Joseph Medical Center, Providence Tarzana Medical Center, Valley Presbyterian Hospital, Northridge Hospital Medical Center, Encino Hospital, Sherman Oaks Hospital, Harbor UCLA Medical Center and Olive View UCLA Medical Center.
Dr. David obtained his undergraduate education at Stanford University and his medical degree at Thomas Jefferson University in Philadelphia. He trained in general surgery and completed his urology residency at UCLA Medical Center in Los Angeles. Dr. David is a fellow of the American College of Surgeons, a member of the American Urological Association, the American Medical Association, and the California Urologic Association. He is also a member of the American Association of Clinical Urologists, American Lithotripsy Society, Society of Laparoendoscopic Surgeons and Society of Urologic Prosthetic Surgeons.
"We are very fortunate to have Dr. Richard David join our Board. Dr. David is a renowned urologic surgeon who brings us a wealth of clinical knowledge and experience. We are honored that Dr. David has agreed to serve on the Board for Qualigen," said Michael S. Poirier, Chairman of the Board.
About Qualigen, Inc.
Qualigen, Inc. is a medical device company focused on the development, production and commercialization of innovative medical technologies, including its flagship FastPack® point-of-care immunoassay system and novel therapeutic technologies for treatment of cancers and infectious diseases. For more information, visit www.qualigeninc.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/richard-david-md-facs-joins-qualigens-board-of-directors-300484312.html
SOURCE Qualigen, Inc.
Subscribe to our Free Newsletters!
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can ...
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...View All